The American Society for Apheresis (ASFA) Board of Directors has made the difficult decision not to proceed with the ASFA 2020 Annual Meeting, originally scheduled for May 6 – 9, 2020 in Austin, Texas. This decision was made after careful consideration and comprehensive evaluation of currently available information related to the novel coronavirus (COVID-19) outbreak.
ASFA has been closely monitoring the rapidly increasing domestic and worldwide developments during the last several weeks related to COVID-19. This evidence-based decision was made after a thorough review and discussion of all factors impacting the Annual Meeting, including the U.S. government’s enforcement of restrictions on international travelers to enter the U.S.; the imposition of travel restrictions issued by U.S. government agencies, cancer centers, academic institutions, and pharmaceutical and biotech companies; and the counsel of infectious disease experts. It is clear that all of these elements significantly affect the ability of delegates, speakers, presenters of abstracts, and exhibitors to participate fully in the Annual Meeting.
The ASFA Board of Directors is currently assessing the feasibility of rescheduling the Annual Meeting for later this year. We thank all of our members and stakeholders for their patience and support at this time. Additional information regarding hotel reservation cancellations, registration refunds, and meeting logistics will be communicated via email and on the website within the next two weeks.